Phase I/II clinical trial of ZM-02 ophthalmic injection in patients with advanced retinitis pigmentosa. (chinadrugtrials.org.cn) - Oct 19, 2026 - P1/2 | N=15 | Not yet recruiting | Sponsor: Zhongmou Medical Technology (Shanghai) Co., Ltd.
New P1/2 trial • Genetic Disorders • Inherited Retinal Dystrophy • Ocular Inflammation • Ophthalmology • Retinal Disorders • Retinitis Pigmentosa
|